Promoter hypermethylation of SFRP1, 2, 4, and 5 has been reported which correlates with the expression and cancer stage in case of breast cancer and colorectal cancer (Suzuki et al., 2002; Fujikane et al., 2010; Li et al., 2018). Here, SFRP1 is linked to breast cancer.